Targeted pathway mining reveals novel modified hexapeptides from the demiguisin family
Abstract
Following the discovery of the piperazic acid (Piz)-containing hexapeptide demiguisin A from a toxic bird-associated Amycolatopsis strain, we aimed to investigate the structural diversity and bioactive potential of this natural product family. Here, we used the dmg biosynthetic gene cluster from Amycolatopsis sp. PS_44_ISF1 as a pathway mining probe to search for alternative demiguisin A producers. A global search identified only one other soil-derived Amycolatopsis sp. NBC_01488, encoding a highly syntenic pathway. Under feather-mimicking conditions, PS_44_ISF1 demonstrated enhanced growth and metabolite production relative to NBC_01488. Despite phylogenomic distance, both strains produced shared metabolites, while NBC_01488 yielded more abundant demiguisins, enabling the isolation of five novel derivatives characterized by two Piz-moieties with different hydroxylation patterns and glycine truncation. Two congeners displayed potent activity against the avian pathogen Mycobacterium intracellulare and moderate activity against Mycobacterium tuberculosis . These findings show that targeted pathway mining guided the expansion of the chemical diversity of Piz-modifications and demiguisin congeners with promising anti- Mycobacterium activity.
Related
- Modified Xiaoyaosan Regulates the Neuro-Immune Microenvironment in Chronic Stress: A Preclinical Meta-Analysis and NF-kappaB Pathway Mechanism Exploration
- Hippo pathway in cancer ferroptosis: from mechanism insights to targeted therapies
- Chitosan nanoparticles functionalised with protocatechuic acid improve colon-targeted pazopanib delivery with multi-pathway therapeutic regulation and pharmacokinetic optimisation in colorectal cancer
- Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition
- Synthesis and Preliminary Biological Evaluation of a Structurally Modified Niraparib-Based PARP-Targeted PET Tracer for Tumor Imaging
BibTeX
@article{decker2026targeted,
title = {{Targeted pathway mining reveals novel modified hexapeptides from the demiguisin family}},
author = {Tanya Decker and Marie Dayras and Lena Schweizer and Sari Rasheed and Franziska Fries and Bulisa Iova and Kasun H. Bodawatta and Knud Andreas Jønsson and Rolf Müller and Christine Beemelmanns},
journal = {Communications Chemistry},
year = {2026},
month = oct,
doi = {10.1038/s42004-026-02250-w},
url = {https://www.nature.com/articles/s42004-026-02250-w},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Targeted pathway mining reveals novel modified hexapeptides from the demiguisin family
AU - Tanya Decker
AU - Marie Dayras
AU - Lena Schweizer
AU - Sari Rasheed
AU - Franziska Fries
AU - Bulisa Iova
AU - Kasun H. Bodawatta
AU - Knud Andreas Jønsson
AU - Rolf Müller
AU - Christine Beemelmanns
PY - 2026
DA - 2026/10/17
JO - Communications Chemistry
DO - 10.1038/s42004-026-02250-w
UR - https://www.nature.com/articles/s42004-026-02250-w
AB - Following the discovery of the piperazic acid (Piz)-containing hexapeptide demiguisin A from a toxic bird-associated Amycolatopsis strain, we aimed to investigate the structural diversity and bioactive potential of this natural product family. Here, we used the dmg biosynthetic gene cluster from Amycolatopsis sp. PS_44_ISF1 as a pathway mining probe to search for alternative demiguisin A producers. A global search identified only one other soil-derived Amycolatopsis sp. NBC_01488, encoding a highly syntenic pathway. Under feather-mimicking conditions, PS_44_ISF1 demonstrated enhanced growth and metabolite production relative to NBC_01488. Despite phylogenomic distance, both strains produced shared metabolites, while NBC_01488 yielded more abundant demiguisins, enabling the isolation of five novel derivatives characterized by two Piz-moieties with different hydroxylation patterns and glycine truncation. Two congeners displayed potent activity against the avian pathogen Mycobacterium intracellulare and moderate activity against Mycobacterium tuberculosis . These findings show that targeted pathway mining guided the expansion of the chemical diversity of Piz-modifications and demiguisin congeners with promising anti- Mycobacterium activity.
SN - 2399-3669
ER -